Charles Hardin, MD
Family Medicine · Salyersville, KYNPI 1447247978
Payments from drug & device makers
Across 14 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$93
- Organogenesis Inc.$58
- Polynovo North America LLC$36
- Mimedx Group, Inc.$28
- Convatec Inc.$17
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$17
- plus $14 from 1 others
What the payments were for
- Food & beverage$263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $93 |
| Organogenesis Inc. | 3 | $58 |
| Polynovo North America LLC | 2 | $36 |
| Mimedx Group, Inc. | 1 | $28 |
| Convatec Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$263 in reported general payments places this provider in the 30th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 284 | $85,044 |
| XifaxanRifaximin | 26 | $54,452 |
| ErtapenemErtapenem Sodium | 70 | $33,509 |
| EntrestoSacubitril/Valsartan | 56 | $28,832 |
| LinzessLinaclotide | 44 | $25,472 |
| JanuviaSitagliptin Phosphate | 73 | $20,739 |
| Budesonide | 135 | $20,351 |
| FarxigaDapagliflozin Propanediol | 67 | $18,899 |
| JardianceEmpagliflozin | 55 | $16,330 |
| Vancomycin Hcl | 47 | $16,242 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 54 | $16,207 |
| XareltoRivaroxaban | 51 | $14,751 |
| Gvoke Hypopen 2-PackGlucagon | 19 | $12,737 |
| MyrbetriqMirabegron | 51 | $12,496 |
| TradjentaLinagliptin | 47 | $12,324 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Salyersville
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.